Medical device manufacturer Cepheid (CPHD) continued its climb, up 22.1% in preopen trading on the Instinet ECN.
The stock closed up more than 86% in the regular session Tuesday, largely in reaction to the current anthrax scare. Also Tuesday, an article in Tuesday's
New York Times
mentioned the company's portable technology for pathogen detection and identification.
According to the article, the company hopes to supply prototypes of the device to the Army. The suitcase-sized unit can perform a genetic test for a pathogen in 30 minutes, compared with the hours or days it now takes, the article says.